TRIA Preps FDA Submission For OTC Skin Rejuvenating Laser, Files For IPO

Aesthetic device maker plans to file a 510(k) this year with FDA for its over-the-counter, non-ablative laser to treat facial wrinkles, supported in part by proceeds from an initial public stock offering worth up to $86.3 million.